Shares of beleaguered Canadian drugmaker Valeant Pharmaceuticals were on the rise again Tuesday after Real Money’s James Passeri reported that famed short seller Andrew Left had reversed tack on the stock. Previously Left and had warned about the company’s pricing problems and looming regulatory issues and was one of the factors behind massive losses in Valeant shares. Passeri explains why Left has changed his tune and what’s next on his radar.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
